Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02122809
Title Phase I Study of Chiauranib in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Chipscreen Biosciences, Ltd.
Age Groups: adult
Covered Countries

Facility Status City State Zip Country Details
Cancer Hospital, Chinese Academy of Medical Sciences Beijing Beijing 100021 China Details
*Shaded cells indicate that there was no data available from for the field